K201208

Substantially Equivalent

Halo AF Detection System

Applicant: Livmor
Product code: DXH
Advisory panel: Cardiovascular
Date received: 2020-05-05
Decision date: 2020-09-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.